JP2024545507A5 - - Google Patents
Info
- Publication number
- JP2024545507A5 JP2024545507A5 JP2024534532A JP2024534532A JP2024545507A5 JP 2024545507 A5 JP2024545507 A5 JP 2024545507A5 JP 2024534532 A JP2024534532 A JP 2024534532A JP 2024534532 A JP2024534532 A JP 2024534532A JP 2024545507 A5 JP2024545507 A5 JP 2024545507A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- vector
- tnnc1
- polynucleotide
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288255P | 2021-12-10 | 2021-12-10 | |
| US63/288,255 | 2021-12-10 | ||
| PCT/US2022/081282 WO2023108129A1 (en) | 2021-12-10 | 2022-12-09 | Troponin c (tnnc1) gene therapy using aav vector |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545507A JP2024545507A (ja) | 2024-12-09 |
| JP2024545507A5 true JP2024545507A5 (enExample) | 2025-10-29 |
Family
ID=86731323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534532A Pending JP2024545507A (ja) | 2021-12-10 | 2022-12-09 | Ａａｖベクターを用いたトロポニンｃ（ｔｎｎｃ１）遺伝子治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240335566A1 (enExample) |
| EP (1) | EP4444893A4 (enExample) |
| JP (1) | JP2024545507A (enExample) |
| CN (1) | CN118613591A (enExample) |
| CA (1) | CA3240616A1 (enExample) |
| WO (1) | WO2023108129A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE055862T2 (hu) | 2016-04-20 | 2021-12-28 | Centro De Investig Energeticas | Készítmények és eljárások PKLR fokozott génexpressziójára |
| SG11202002263TA (en) | 2017-10-16 | 2020-04-29 | Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas | Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency |
| WO2019200167A1 (en) | 2018-04-11 | 2019-10-17 | Rocket Pharmaceuticals, Ltd. | Compositions and methods for stem cell transplant |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5553547B2 (ja) * | 2009-07-14 | 2014-07-16 | 俊一 梶岡 | トロポニン含有医薬組成物 |
| EP2714709B1 (en) * | 2011-05-26 | 2018-04-18 | University of Washington | Compositions for use in cell and gene based methods to improve cardiac function |
| EP2792742A1 (en) * | 2013-04-17 | 2014-10-22 | Universitätsklinikum Hamburg-Eppendorf (UKE) | Gene-therapy vectors for treating cardiomyopathy |
| WO2018178067A1 (en) * | 2017-03-27 | 2018-10-04 | Vrije Universiteit Brussel | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof |
| EP3947700A4 (en) * | 2019-04-01 | 2023-01-04 | Tenaya Therapeutics, Inc. | Adeno-associated virus with engineered capsid |
| AR126660A1 (es) * | 2021-07-28 | 2023-11-01 | Univ Brussel Vrije | Mejorando la eficacia de la terapia génica dirigida a músculos |
-
2022
- 2022-12-09 EP EP22905416.8A patent/EP4444893A4/en active Pending
- 2022-12-09 US US18/718,023 patent/US20240335566A1/en active Pending
- 2022-12-09 CA CA3240616A patent/CA3240616A1/en active Pending
- 2022-12-09 CN CN202280090177.8A patent/CN118613591A/zh active Pending
- 2022-12-09 JP JP2024534532A patent/JP2024545507A/ja active Pending
- 2022-12-09 WO PCT/US2022/081282 patent/WO2023108129A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538519A5 (enExample) | ||
| JP2024545507A5 (enExample) | ||
| JP2023536618A5 (enExample) | ||
| US20220331409A1 (en) | Factor ix gene therapy | |
| JP2024546103A5 (enExample) | ||
| JP2025512574A5 (enExample) | ||
| JP2025179046A5 (enExample) | ||
| IL278213B1 (en) | A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd) | |
| AU2021320902A1 (en) | Plakophilin-2 (PKP2) gene therapy using AAV vector | |
| JP2023536902A5 (enExample) | ||
| JP2024523707A5 (enExample) | ||
| JP2022520232A5 (enExample) | ||
| JP2024099770A5 (enExample) | ||
| JP2023088902A5 (enExample) | ||
| JP2023535576A5 (enExample) | ||
| JP2021533805A5 (enExample) | ||
| JP2022531861A5 (enExample) | ||
| JP2025505662A5 (enExample) | ||
| US20260049336A1 (en) | Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof | |
| JP2021500922A5 (enExample) | ||
| JP2022541793A5 (enExample) | ||
| JP2023537903A5 (enExample) | ||
| JP2023065516A5 (enExample) | ||
| JP2023503850A5 (enExample) | ||
| JP2021520232A5 (enExample) |